Product Name :
(R)-Lisofylline
CAS No.:
100324-81-0
Purity :
> 99%
Shipping:
Shipped on dry ice.
Storage :
Powder: -20 °C, 3 years; 4 °C, 2 yearsIn solvent: -80 °C, 6 months; -20 °C, 1 month
SMILES:
Product Description :
(R)-Lisofylline ((R)-Lisophylline) is a (R)-enantiomer of the metabolite of Pentoxifylline with anti-inflammatory properties.{{Etrolizumab} MedChemExpress|{Etrolizumab} Cytoskeleton|{Etrolizumab} Biological Activity|{Etrolizumab} Purity|{Etrolizumab} manufacturer|{Etrolizumab} Epigenetic Reader Domain} (R)-Lisofylline is a lysophosphatidic acid acyltransferase inhibitor with an IC50 of 0.{{Teduglutide} medchemexpress|{Teduglutide} Vitamin D Related/Nuclear Receptor|{Teduglutide} Protocol|{Teduglutide} Purity|{Teduglutide} manufacturer|{Teduglutide} Autophagy} 6 µM and interrupts IL-12 signaling-mediated STAT4 activation.PMID:24065671 (R)-Lisofylline has the potential for type 1 diabetes, autoimmune disorders research.
Formula:
C13H20N4O3
Molecular Weight :
280.32
Synonyms:
(R)-Lisophylline
Additional Information:
|CAS No. 100324-81-0 ; |Synonyms (R)-Lisophylline ; |Formula C13H20N4O3 ; |Molecular Weight 280.32 ; |Product Description (R)-Lisofylline ((R)-Lisophylline) is a (R)-enantiomer of the metabolite of Pentoxifylline with anti-inflammatory properties. (R)-Lisofylline is a lysophosphatidic acid acyltransferase inhibitor with an IC50 of 0.6 µM and interrupts IL-12 signaling-mediated STAT4 activation. (R)-Lisofylline has the potential for type 1 diabetes, autoimmune disorders research. ; |Format Solid ; |Purity > 99% ; |Shipping Shipped on dry ice. ; |Storage Powder: -20 °C, 3 years; 4 °C, 2 yearsIn solvent: -80 °C, 6 months; -20 °C, 1 month ; |Solubility Overview Soluble in DMSO